The American Society for Colposcopy and Cervical Pathology (ASCCP) Guidelines have been updated to include dual-stain biomarker as an acceptable triage option for high-risk HPV positive test results.  

Not every HPV-positive woman will develop cervical cancer, so triage can determine who is most at risk and will benefit from more immediate follow-up, and who is at low risk and can be given more time to clear the infection on her own. CINtec ® PLUS is a triage cytology test that helps stratify disease risk immediately, giving clinicians confidence when selecting the appropriate management for women at every level of risk.

Download the brochure below to learn more.

Additionally, fill out the form below to have a Roche Account Executive contact you.